IVBXF (Innovent Biologics) Change In Inventory : $25 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Innovent Biologics Change In Inventory?

Innovent Biologics's change in inventory for the quarter that ended in Dec. 2024 was $-12 Mil. It means Innovent Biologics's inventory increased by $12 Mil from Jun. 2024 to Dec. 2024 .

Innovent Biologics's change in inventory for the fiscal year that ended in Dec. 2024 was $25 Mil. It means Innovent Biologics's inventory declined by $25 Mil from Dec. 2023 to Dec. 2024 .

Innovent Biologics's Total Inventories for the quarter that ended in Dec. 2024 was $113 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Innovent Biologics's Days Inventory for the quarter that ended in Dec. 2024 was 166.03.

Inventory Turnover measures how fast the company turns over its inventory within a year. Innovent Biologics's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Innovent Biologics's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.14.

Innovent Biologics Change In Inventory Historical Data

The historical data trend for Innovent Biologics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovent Biologics Change In Inventory Chart

Innovent Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-47.62

-101.00

-15.12

50.27

24.81

Innovent Biologics Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial												5.54	16.25	33.98	37.10	-12.16

Innovent Biologics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $25 Mil.

Innovent Biologics (OTCPK:IVBXF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Innovent Biologics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	104.0455	/	114.365	*	365 / 2
	=	166.03

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Innovent Biologics's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	114.365	/	104.0455
	=	1.10

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Innovent Biologics's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	104.0455	/	751.246
	=	0.14

Innovent Biologics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Innovent Biologics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovent Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovent Biologics Inc (OTCPK:IVBXF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

IVBIY:USA 01801:Hong Kong 6IB:Germany

Address

168 Dongping Street, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215123

Website

https://www.innoventbio.com

Innovent Biologics, or Innovent, is one of the leading biotechnology companies in China. Listed on the Hong Kong Exchange in 2018, Innovent has 12 commercialized oncology products and three commercialized nononcology products as of March 2025. Its core asset is Tyvyt, a PD-1 inhibitor included in the National Reimbursement Drug Lists for the first-line treatment of five major cancers. Innovent has over 30 strategic collaborations with global pharmaceutical or biotech companies, such as Eli Lilly, Roche Group, Incyte, and others. It also has a wide spectrum of therapeutic targets in early clinical developments. Among its upcoming pipelines, the potential blockbuster is Mazdutide, a therapy for obesity and type 2 diabetes.